Journal article
A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening.
- Abstract:
-
BACKGROUND: Prostate-specific antigen (PSA) has modest specificity for prostate cancer. A panel of four kallikrein markers (total PSA, free PSA, intact PSA, and kallikrein-related peptidase 2) is a highly accurate predictor of biopsy outcome. The clinical significance of biopsy-detectable cancers in men classified as low-risk by this panel remains unclear. METHODS: The Malmö Diet and Cancer study is a population-based cohort of 11,063 Swedish men aged 45 to 73 providing a blood sample at base...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
- Volume:
- 20
- Issue:
- 2
- Pages:
- 255-261
- Publication date:
- 2011-02-01
- DOI:
- EISSN:
-
1538-7755
- ISSN:
-
1055-9965
- Source identifiers:
-
365882
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:365882
- UUID:
-
uuid:b32599c3-97b1-4fff-b9ef-57185470241f
- Local pid:
- pubs:365882
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2011
If you are the owner of this record, you can report an update to it here: Report update to this record